Morgan Stanley Form 144 lists 800 RSUs; RSKD insider 10b5-1 sales reported

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Section 144 notice relating to 800 Restricted Stock Units issued 07/01/2023.

The filing also lists recent 10b5-1 sales by Aglika Dotcheva: $100,270 for 20,000 shares on 07/01/2026, $98,039.20 for 19,600 shares on 06/01/2026, and $2,000 for 400 shares on 05/19/2026.

Insights

Securities Compliance Counsel

Section 144 notice filed for 800 Restricted Stock Units; multiple 10b5-1 sales reported.

The filing lists 800 Restricted Stock Units dated 07/01/2023 as the securities to be sold under the Section 144 notice. Section 144 notices inform the broker and market of an intended sale by an affiliate or control person.

Separately, the excerpt records three 10b5-1 sales by Aglika Dotcheva on 05/19/2026, 06/01/2026, and 07/01/2026, with reported proceeds shown in the filing. Timing and cash‑flow treatment are those of the sales themselves as disclosed.

Key Figures

RSUs to be sold: 800 shares 10b5-1 sale on 07/01/2026: 20,000 shares 10b5-1 sale on 06/01/2026: 19,600 shares +1 more

4 metrics

RSUs to be sold 800 shares Restricted Stock Units issued <date>07/01/2023</date>

10b5-1 sale on 07/01/2026 20,000 shares Proceeds reported <money>$100,270</money>

10b5-1 sale on 06/01/2026 19,600 shares Proceeds reported <money>$98,039.20</money>

10b5-1 sale on 05/19/2026 400 shares Proceeds reported <money>$2,000</money>

Key Terms

Section 144, Restricted Stock Units, 10b5-1

3 terms

Section 144 regulatory

"144: Securities To Be Sold"

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 800 | 07/01/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for AGLIKA DOTCHEVA ... 07/01/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/02/2026 - 04:34 PM Accepted by SEC EDGAR 07/02/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	800	4016.00	104034048	07/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2023	Restricted Stock Units	Issuer			800	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/01/2026	20000	100270.00
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	06/01/2026	19600	98039.20
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	05/19/2026	400	2000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for RSKD show?

It notifies a planned sale of 800 Restricted Stock Units issued on 07/01/2023. The notice identifies the security type and quantity being reported under Section 144 without detailing execution timing or buyer counterparties.

Who recorded 10b5-1 sales in this filing for RSKD?

Aglika Dotcheva reported three 10b5-1 sales: 400 shares on 05/19/2026, 19,600 on 06/01/2026, and 20,000 on 07/01/2026, with proceeds listed in the excerpt.

How much cash was reported from the largest sale listed?

The largest single sale in the excerpt shows proceeds of $100,270 for 20,000 shares on 07/01/2026. The filing lists the dollar amounts reported for each 10b5-1 transaction.

Does the Form 144 disclose when the 800 RSUs will be sold?

No specific sale execution date for the 800 RSUs is provided in the excerpt. The notice lists the securities and their issuance date (07/01/2023) but does not state a planned sale date.